Accolade to Participate in Upcoming Investor Conferences
Accolade, Inc. (NASDAQ: ACCD) will participate in two upcoming investor conferences: the BTIG Virtual MedTech Conference on February 17, 2021, at 4:00 p.m. E.T. and the SVB Leerink Global Healthcare Conference on February 24, 2021, at 9:20 a.m. E.T. Audio webcasts and presentation materials will be available at ir.accolade.com. Accolade offers personalized health and benefits solutions, aiding users in navigating the healthcare system, achieving high consumer satisfaction ratings and lowering healthcare costs.
- None.
- None.
SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the following upcoming investor conferences:
- The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference, including a fireside chat on Wednesday, February 17, 2021 at 4:00 p.m. E.T.
- The SVB Leerink Global Healthcare Conference, including a fireside chat presentation on Wednesday, February 24, 2021 at 9:20 a.m. E.T.
The audio webcasts and related presentation materials from both events will be available at ir.accolade.com.
About Accolade, Inc.
Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Using a blend of cloud-based technologies, specialized support from Accolade Health Assistants® and Clinicians, and integrated data and programs across mobile, online and phone, Accolade navigates people through the healthcare system with trust, empathy and ease. Employers offer Accolade to employees and their families as the single place to turn for all health, healthcare, and benefits questions or concerns, increasing their engagement in benefits and connecting them to high-quality providers and care. By empowering members to make better decisions about their health, Accolade can support members in lowering the cost and complexity of healthcare while achieving consumer satisfaction ratings over 90 percent and an NPS of 60.
Investor Contact:
Todd Friedman, Investor Relations, 484-532-5200, Todd.Friedman@accolade.com
Asher Dewhurst, Investor Relations, 443-213-0503, accolade@westwicke.com
Media Contact:
Megan Torres, Public Relations, 206-926-8180, Megan.Torres@accolade.com
Source: Accolade
FAQ
What investor conferences will Accolade, Inc. participate in February 2021?
What time is Accolade's fireside chat at the BTIG Conference?
When is Accolade's presentation at the SVB Leerink Global Healthcare Conference?